Overview
Yasuto Yoneshima practices practicing medicine in Fukuoka, Japan.
Yoneshima is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
They are actively involved in clinical research, co-authoring 81 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yasuto Yoneshima
Is Yasuto Yoneshima a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Yasuto Yoneshima is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yasuto Yoneshima participate in research or clinical trials?
Yes. Yasuto Yoneshima has published 81 articles and abstracts on conditions like Lung Cancer. You can view a list of Yasuto Yoneshima's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerYoneshima isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Yoneshima isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- EGFR Positive Lung CancerYoneshima isAdvanced. Learn about EGFR Positive Lung Cancer.
- Small Cell Lung Cancer (SCLC)Yoneshima isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- Acute Interstitial PneumoniaYoneshima isExperienced. Learn about Acute Interstitial Pneumonia.
- Anal CancerYoneshima isExperienced. Learn about Anal Cancer.
- ChondrosarcomaYoneshima isExperienced. Learn about Chondrosarcoma.
- Idiopathic Pulmonary FibrosisYoneshima isExperienced. Learn about Idiopathic Pulmonary Fibrosis.
- Interstitial Lung DiseaseYoneshima isExperienced. Learn about Interstitial Lung Disease.
- Low Sodium LevelYoneshima isExperienced. Learn about Low Sodium Level.
- Lung AdenocarcinomaYoneshima isExperienced. Learn about Lung Adenocarcinoma.
- MediastinitisYoneshima isExperienced. Learn about Mediastinitis.
- Pleural EffusionYoneshima isExperienced. Learn about Pleural Effusion.
- PneumoniaYoneshima isExperienced. Learn about Pneumonia.
- Pulmonary FibrosisYoneshima isExperienced. Learn about Pulmonary Fibrosis.
- Secondary Adrenal InsufficiencyYoneshima isExperienced. Learn about Secondary Adrenal Insufficiency.
- Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)